HISTOINDEX AND A*STAR PARTNER TO ADVANCE EARLY-STAGE DEVELOPMENT OF PIPELINE THERAPIES FOR FIBROTIC DISEASES
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Mon, 19 October 2026
What it is about
Prnewswire HistoindexTechnology OrganisationBiomedical Research CouncilTerms Of ServiceAgency For ScienceManila, Manila, PhilippinesSingaporeColorado, United StatesDenver, Colorado, United States
Who published it, and when
How it spread - 1 original report
Mon, 19 October 2026
1 report- manilatimes.net03:55first to report
SINGAPORE, Oct. 19, 2026 /PRNewswire/ -- HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agency, have signed a Memorandum of Understanding (MoU) to collaborate on the preclinical evaluation and characterization of therapeutic candidates for various fibrotic diseases, including cancer-associated fibrosis.